Articles tagged with Semen
A recent study by Queen's University researchers has found a link between trichloroethylene (TCE) exposure and male infertility. TCE, used in various industrial applications, is metabolized in the human reproductive tract and can adversely affect sperm development.
A study of 97 healthy men aged 22-80 found significant age-related decreases in semen volume and sperm motility. Semen quality is a proxy for fertility, suggesting that men may become progressively less fertile as they age.
A study of 97 healthy men found that semen quality decreased with age, particularly in sperm motility. The researchers discovered a 0.7% decrease in sperm motility per year, impacting fertility from age 22 to 80.
A recent review by the European Society of Human Reproduction and Embryology found that while there is a slightly higher risk of major birth defects after ICSI and IVF, the absolute risk is small. Additionally, new research has shown that ICSI children have normal development by the time they start school.
Researchers have developed a mouse model to study the transmission of cell-associated HIV in women, finding that hormonal treatments and agents disrupting lipid rafts can prevent infection. The study reveals the importance of understanding cell-associated HIV transmission for developing effective prevention strategies.
A new study proposes revised guidelines for classifying semen samples as normal or abnormal, potentially rewriting laboratory standards used for 50 years. The research suggests that male infertility is not as clear-cut as current guidelines suggest, and that a 'gray zone' of borderline semen samples requires new treatment approaches.
New guidelines for assessing male fertility provide a more reliable means of estimating fertility, helping specialists tailor treatments to individual patient circumstances. The revised standards identify key parameters, including sperm count, motility, and morphology, to better determine a man's likelihood of fathering a child.
Researchers found AAV DNA in 38% of men with abnormal semen analysis, but only 4.6% of those with normal semen. Further studies are needed to assess the link between AAV and infertility.
A randomized trial found that zinc acetate lozenges reduced the duration and symptoms of colds, but caution is needed due to potential copper deficiency risks. Antiretroviral therapy also showed promising results in reducing HIV transmission in semen, but with concerns about drug resistance.
Researchers at USC found no significant change in average sperm count over three decades, contradicting previous studies. Sperm abnormalities were common, but did not impact overall fertility.
Researchers found three distinct shedding patterns in HIV-positive men, related to viral sources and genetic strains. This discovery shifts the focus of AIDS vaccine research from blood-borne viruses to multiple strains in semen.
Researchers at Thomas Jefferson University found latent HIV in the semen of seven infected men taking HAART, which may be transmissible. The study suggests that even if detectable virus is not present in blood, individuals should practice safe sex to prevent transmission.
A study by UNC researchers confirms the presence of mutated, drug-resistant human immunodeficiency virus in the semen of men taking antiviral medications. The study found that if men do not have adequate suppression of their virus, they are likely to shed drug-resistant strains of HIV in their genital secretions.
Researchers at the University of Pittsburgh found that HIV-1 viral load in semen can fluctuate greatly and does not correspond to viral levels in blood, requiring new testing methods to monitor transmission risk. Testing viral load levels in semen may offer physicians a better way to assess transmission risk and target treatments.
Researchers found that viral load in semen increases with progression of the disease in most patients. Using antiviral therapy, they were able to reduce viral load in semen to undetectable levels in six patients.